Conjugated linoleate reduces prostate cancer viability whereas the effects of oleate and stearate are cell line-dependent

Anticancer Research

Volumn 33, Issue 10, 2013, Pages 4395-4400

  Hagen, Rachel M ^a   Rhodes, Anthony ^a,b   Ladomery, Michael R ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Fatty acids; Linoleate; Proliferation; Prostate cancer

Indexed keywords

ACYL COENZYME A DESATURASE; CONJUGATED LINOLEIC ACID; OLEIC ACID; STEARIC ACID;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT RESPONSE;

FATTY ACIDS; LINOLEATE; PROLIFERATION; PROSTATE CANCER;

ACETYL-COA CARBOXYLASE; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; FATTY ACID SYNTHASE, TYPE I; GENE EXPRESSION; GLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; HUMANS; LINOLEIC ACIDS, CONJUGATED; LIPID METABOLISM; MALE; OLEIC ACID; PPAR GAMMA; PROSTATIC NEOPLASMS; STEARIC ACIDS;

EID: 84891358239     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Liu Y, Zuckier LS and Ghesani NV: Dominant uptake of fatty acid over glucose by prostate cells: A potential new diagnostic and therapeutic approach. Anticancer Res 30: 369-374, 2010.
2. Pandian SS, Eremin OE, McClinton S, Wahle KW and Heys SD: Fatty acids and prostate cancer: Current status and future challenges. J R Coll Surg Edinb 144: 352-361, 1999.
3. Epstein MM, Kasperzyk JL, Mucci LA, Giovannucci E, Price A, Wolk A, Hakansson N, Fall K, Andersson SO and Andren O: Dietary fatty acid intake and prostate cancer survival in Orebro County, Sweden. Am J Epidemiol 176: 240-252, 2012.
4. Berquin IM, Edwards IJ, Kridel SJ and Chen YQ: Polyunsaturated fatty acid metabolism in prostate cancer. Cancer Metastasis Rev 30: 295-309, 2011.
5. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF and Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23, 1979.
6. Stone KR, Mickey DD, Wunderli H, Mickey GH and Paulson DF: Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21: 274-281, 1978.
7. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK and Sandberg AA: The LNCaP cell line-A new model for studies on human prostatic carcinoma. Prog Clin Biol Res 37: 115-132, 1980.
8. Korenchuk S, Lehr JE, MClean L, Lee YG, Whitney S, Vessella R, Lin DL and Pienta KJ: VCaP, a cell-based model system of human prostate cancer. In Vivo 15: 163-168, 2001.
9. Cussenot O, Berthon P, Berger R, Mowszowicz I, Faille A, Hojman F, Teillac P, Le Duc A and Calvo F: Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol 146: 881-886, 1991.
10. Cousin SP, Hugl SR, Wrede CE, Kajio H, Myers MG Jr. and Rhodes CJ: Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. Endocrinology 142: 229-240, 2001.
11. Applied Biosystems: Guide to Performing Relative Quantitation of Gene Expression Using Real-Time Quantitative PCR, 2008. (http://www3. appliedbiosystems.com/cms/groups/mcb-support/documents/generaldocuments/ cms-042380.pdf)
12. Rose DP and Connolly JM: Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate 18: 243-254, 1991.
13. Hughes-Fulford M, Chen Y and Tjandrawinata RR: Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells. Carcinogenesis 22: 701-707, 2001.
14. Song HJ, Sneddon AA, Barker PA, Bestwick C, Choe SN, McClinton S, Grant I, Rotondo D, Heys, SD and Wahle KW: Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells. Nutr Cancer 49: 100-108, 2004.
15. Cesano A, Visonneau S, Scimeca JA, Kritchevsky D and Santoli D: Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res 18: 1429-1434, 1998.
16. Ochoa JJ, Farquharson AJ, Grant I, Moffat LE, Heys SD and Wahle KW: Conjugated linoleic acids (CLAs) decrease prostate cancer cell proliferation: Different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis 25: 1185-1191, 2004.
17. Wei Y, Wang D, Topczewski F and Pagliassotti MJ: Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab 291: E275-281, 2006.
18. Vlietstra RJ, van Alewijk DC, Hermans KG, van Steenbrugge GJ and Trapman J: Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res 58: 2720-2723, 1998.
19. Swinnen JV, Ulrix W, Heyns W and Verhoeven G: Coordinate regulation of lipogenic gene expression by androgens: Evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc Natl Acad Sci USA 94: 12975-12980, 1997.
20. Faas FH, Dang AQ, White J, Schaefer RF and Johnson DE: Decreased prostatic arachidonic acid in human prostatic carcinoma. BJU Int 92: 551-554, 2003.
21. Park WJ, Kothapalli KS, Lawrence P and Brenna JT: FADS2 function loss at the cancer hotspot 11q13 locus diverts lipid signaling precursor synthesis to unusual eicosanoid fatty acids. PLoS One 6(11): e28186, 2011.